Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6 | 152062578 | intron variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152021653 | intron variant | G/T | snv | 1.1E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.040 | 6 | 152012810 | intron variant | G/A | snv | 4.9E-02 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 6 | 152009538 | intron variant | C/T | snv | 8.5E-02 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
6 | 151998730 | intron variant | G/A | snv | 9.8E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 151971471 | intron variant | A/C | snv | 5.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 151950843 | intron variant | G/T | snv | 2.6E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 151950843 | intron variant | G/T | snv | 2.6E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 151950843 | intron variant | G/T | snv | 2.6E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.080 | 6 | 151842832 | intron variant | A/G | snv | 1.0E-03 | 3.8E-04 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.925 | 0.080 | 6 | 151842832 | intron variant | A/G | snv | 1.0E-03 | 3.8E-04 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.070 | 0.857 | 7 | 2007 | 2020 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.070 | 0.857 | 7 | 2007 | 2020 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Neoplasms; Male Urogenital Diseases | 0.050 | 0.800 | 5 | 2012 | 2017 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Neoplasms; Male Urogenital Diseases | 0.050 | 0.800 | 5 | 2012 | 2017 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Mental Disorders | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Behavior and Behavior Mechanisms | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Behavior and Behavior Mechanisms | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Nervous System Diseases; Mental Disorders | 0.030 | 1.000 | 3 | 2014 | 2014 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Cardiovascular Diseases | 0.020 | 0.500 | 2 | 2010 | 2015 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Musculoskeletal Diseases | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2012 | 2012 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2005 | 2013 | |||||||
|
0.583 | 0.680 | 6 | 151842246 | intron variant | A/G | snv | 0.32 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2008 | 2009 |